Protein S Deficiency Medication Savings with TheDrugClub
Members can check active-formulary eligibility and membership pricing for Protein S Deficiency medications. A condition association alone does not establish coverage.
What Is Protein S Deficiency?
Protein S Deficiency is a medical condition that may require prescription treatment. Consult a healthcare professional about appropriate options.
Managing Protein S Deficiency with TheDrugClub
Eligible medications linked to the active formulary may have no additional cost under listed supply, quantity, fill, and fulfillment limits. Other prescriptions may qualify for membership pricing. Confirm current terms before filling.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
About Protein S Deficiency
Protein S deficiency is a genetic or acquired condition that increases your risk of developing dangerous blood clots. This natural protein helps regulate blood clotting, and a shortage can lead to serious health issues. Managing this condition often requires ongoing medication, which can become expensive. TheDrugClub helps members afford these vital treatments, ensuring you can access the care you need without financial strain.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
About Protein S deficiency (from MedlinePlus Genetics)
Protein S deficiency is a disorder that increases the risk of developing blood clots. People with protein S deficiency are at risk of developing a type of clot called a deep vein thrombosis (DVT) that occurs in the deep veins of the arms or legs. A DVT can travel through the bloodstream and lodge in the lungs, causing a life-threatening clot called a pulmonary embolism (PE). Both DVTs and PEs are a type of venous thromboembolism, a general term for blood clots that form in a vein. Factors such as age, surgery, immobility, or pregnancy can increase the risk of clotting in people with protein S deficiency. In addition, people who have protein S deficiency and another inherited blood clotting disorder may have a higher risk of developing blood clots. Venous thromboembolism occurs in approximately fifty to sixty percent of people with protein S deficiency.
In rare cases, individuals have a severe form of protein S deficiency with signs and symptoms that develop soon after birth. Affected infants typically develop a life-threatening blood clotting disorder called purpura fulminans. Purpura fulminans is characterized by the formation of blood clots within small blood vessels throughout the body. These blood clots disrupt normal blood flow and can lead to the death of tissues (necrosis). Widespread blood clotting uses up all available blood clotting proteins. As a result, the body can no longer create clots, and bleeding occurs in various parts of the body. This abnormal bleeding often appears as large, purple skin lesions. Affected individuals who survive the newborn period may experience recurrent episodes of purpura fulminans.
Source: MedlinePlus Genetics, U.S. National Library of Medicine
This information is educational and is not medical advice.